Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 856
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Tuloxxin 100 mg/ml V/DCP/18/0079 KRKA, d.d., Novo mesto, Slovēnija QJ01FA94 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tulathromycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 28-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] 171221LI (10-Apr-2024)
Labelling text: [PDF] 171221M (10-Apr-2024)
Summary of product characteristics: [DOCX] 171221ZA (10-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0079-01 1 Stikla flakons, 50 ml -
V/DCP/18/0079-02 1 Stikla flakons, 100 ml -
V/DCP/18/0079-03 1 Stikla flakons, 250 ml -
Tolfelab 40 mg/ml V/DCP/22/0045 Labiana Life Sciences S.A., Spānija QM01AG02 cattle; pigs; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tolfenamic acid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Labiana Life Sciences S.A., Spānija
Date of authorisation/renewal: 30-Nov-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-Nov-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0045-01 1 Stikla flakons, 20 ml -
V/DCP/22/0045-02 1 Stikla flakons, 50 ml -
V/DCP/22/0045-03 1 Stikla flakons, 100 ml -
V/DCP/22/0045-04 1 Stikla flakons, 250 ml -
Cepritect 250 mg V/DCP/17/0049 Norbrook Laboratories (Ireland) Limited, Īrija QJ51DB90 dry cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cefalonium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Dec-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0049-01 24 Injektors, 3 g -
V/DCP/17/0049-02 60 Injektors, 3 g -
V/DCP/17/0049-03 120 Injektors, 3 g -
Milprazon 16 mg/40 mg - V/DCP/14/0073 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 cats weighing at least 2 kg Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0073-01 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/DCP/14/0073-02 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/DCP/14/0073-03 12 Al/OPA/Al/PVH blisteris, 4 tablete -
Bupredine Multidose vet 0.3 mg/ml V/DCP/15/0048 Le Vet Beheer B.V., Nīderlande QN02AE01 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Buprenorphine hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 20-Dec-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 20122021LI (23-Dec-2021)
Labelling text: [DOCX] 20122021M (23-Dec-2021)
Summary of product characteristics: [DOCX] 20122021ZA (23-Dec-2021)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0048-01 0,3 mg/ml 1 Stikla flakons, 5 ml -
V/DCP/15/0048-02 0,3 mg/ml 1 Stikla flakons, 10 ml -
V/DCP/15/0048-03 0,3 mg/ml 1 Stikla flakons, 20 ml -
V/DCP/15/0048-04 0,3 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/15/0048-05 0,3 mg/ml 1 Stikla flakons, 100 ml -
Ultrapen LA 300 mg/ml V/NRP/98/0939 Norbrook Laboratories (Ireland) Limited, Īrija QJ01CE09 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Procaine benzylpenicillin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 09-Feb-2009
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 15052024_LI (14-May-2024)
Labelling text: [DOCX] 15052024_M (14-May-2024)
Summary of product characteristics: [DOCX] 15052024_ZA (14-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/98/0939-01 300 mg/ml 1 Stikla flakons, 50 ml -
V/NRP/98/0939-02 300 mg/ml 1 Stikla flakons, 100 ml -
Be-Complex - V/NRP/94/0280 Bela-pharm GmbH&Co.KG, Vācija QA11EX cattle; pigs; horses; dogs; cats; minks; foxes Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Thiamine hydrochloride, Riboflavine sodium phosphate, Pyridoxine hydrochloride, Nicotinamide, Calcium pantothenate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 07-Oct-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Aug-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Aug-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Aug-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/94/0280-01 1 Stikla flakons, 50 ml -
V/NRP/94/0280-02 6 Stikla flakons, 50 ml -
V/NRP/94/0280-03 12 Stikla flakons, 50 ml -
V/NRP/94/0280-08 1 Stikla flakons, 100 ml -
V/NRP/94/0280-09 6 Stikla flakons, 100 ml -
V/NRP/94/0280-10 12 Stikla flakons, 100 ml -
V/NRP/94/0280-15 1 Stikla flakons, 250 ml -
V/NRP/94/0280-16 6 Stikla (tumša) flakons, 250 ml -
V/NRP/94/0280-17 12 Stikla flakons, 250 ml -
Nobilis Reo+IB+G+ND - V/NRP/95/0179 Intervet International B.V., Nīderlande QI01AA16 chickens Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated Newcastle disease virus, strain Clone 30,Inactivated reovirus strain 1733 and 2408,Inactivated avian infectious bronchitis virus, strain M41 ,Inactivated infectious bursal disease virus, strain D78
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/95/0179-01 1 Stikla flakons, 1000 deva -
V/NRP/95/0179-02 1 PET pudele, 1000 deva -
Benestermycin - V/NRP/96/0294 Boehringer Ingelheim Vetmedica GmbH, Vācija QJ51RC25 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Penethamate hydroiodide, Benethamine penicillin, Framycetin sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija;Lohmann Pharma Herstellung GmbH, Vācija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0294-01 20 Injektors, 1 deva -
Cobactan LC 75 mg V/NRP/01/1288 Intervet International BV, Nīderlande QJ51DE90 cattle (lactating cows) Vairāk

Medicinal product information

Pharmaceutical form: intramammary ointment
International name (active substance): Cefquinome (as cefquinome sulfate)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Hoechst Roussel Vet, Francija;Intervet International BV, Nīderlande;INTERVET INTERNATIONAL GMBH, Vācija
Date of authorisation/renewal: 03-Aug-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1288-01 75 mg/deva 3 Injektors, 1 deva -
V/NRP/01/1288-02 75 mg/deva 15 Injektors, 1 deva -
V/NRP/01/1288-03 75 mg/deva 20 Injektors, 1 deva -
V/NRP/01/1288-04 75 mg/deva 24 Injektors, 1 deva -
Bovilis IBR marker live - V/NRP/02/1525 Intervet International B.V., Nīderlande QI02AD01 cattle Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Inactivated antigen of BHV-1 (gE) strain GK/D
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Oct-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Oct-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1525-05 1 Stikla flakons, 5 deva -
V/NRP/02/1525-06 10 Stikla flakons, 10 deva -
V/NRP/02/1525-07 10 Stikla flakons, 5 deva -
V/NRP/02/1525-08 1 Stikla flakons, 10 deva -
V/NRP/02/1525-09 1 Stikla flakons, 25 deva -
V/NRP/02/1525-10 10 Stikla flakons, 25 deva -
V/NRP/02/1525-11 1 Stikla flakons (šķīdinātājs stikla flakonā), 50 deva -
V/NRP/02/1525-12 10 Stikla flakons (šķīdinātājs stikla flakonā), 50 deva -
V/NRP/02/1525-13 1 Stikla flakons, 100 deva -
V/NRP/02/1525-14 10 Stikla flakons, 100 deva -
V/NRP/02/1525-15 1 Stikla flakons (šķīdinātājs PET flakonā), 50 deva -
V/NRP/02/1525-16 10 Stikla flakons (šķīdinātājs PET flakonā), 50 deva -
Floron oral solution 100 mg/ml - V/NRP/01/1416 KRKA, d.d., Novo mesto, Slovēnija QJ01BA90 pigs; chickens Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Florfenicol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 19-Jan-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1416-01 100 mg/ml 1 Pudelīte, 100 ml -
V/NRP/01/1416-02 100 mg/ml 1 Flakons, 1000 ml -
Nobilis Reo inac - V/NRP/03/1558 Intervet International B.V., Nīderlande QI01AA04 chickens Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated Reoviruss
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1558-01 1 Stikla flakons, 1000 deva -
V/NRP/03/1558-03 1 PET flakons, 1000 deva -
Bimectin 10 mg/ml V/NRP/07/1703 Bimeda Animal Health Limited, Īrija QP54AA01 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bimeda Animal Health Limited, Īrija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1703-01 10 mg/ml 1 Polietilēna pudele, 50 ml -
V/NRP/07/1703-02 10 mg/ml 1 Polietilēna pudele, 250 ml -
V/NRP/07/1703-03 10 mg/ml 1 Polietilēna pudele, 500 ml -
Marbocyl P 80mg - V/NRP/08/1577 Vetoquinol S.A., Francija QJ01MA93 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 090710LI (19-Jul-2010)
Labelling text: [DOC] 090710_M (19-Jul-2010)
Summary of product characteristics: [PDF] 090710ZA (19-Jul-2010)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1577-01 80 mg 1 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-02 80 mg 2 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-03 80 mg 3 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-04 80 mg 4 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-05 80 mg 5 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-06 80 mg 8 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-07 80 mg 12 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-08 80 mg 16 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-09 80 mg 20 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-10 80 mg 40 Alumīnija blisteris, 6 tablete -
V/NRP/08/1577-11 80 mg 80 Alumīnija blisteris, 6 tablete -
Porcilis Ery - V/NRP/96/0377 Intervet International B.V., Nīderlande QI09AB03 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Erysipelothrix rhusiopathiae, serotype 2, strain M2
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (29-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0377-01 1 Pudelīte, 10 deva -
V/NRP/96/0377-02 1 Pudelīte, 25 deva -
V/NRP/96/0377-03 1 Pudelīte, 50 deva -
V/NRP/96/0377-04 1 Pudelīte, 125 deva -
Nafpenzal DC - V/NRP/93/0034 Intervet International B.V., Nīderlande QJ51RC23 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Procaine benzylpenicillin, Nafcillin, Dihydrostreptomycin sulphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/93/0034-01 4 Injektors, 1 deva -
V/NRP/93/0034-02 20 Injektors, 1 deva -
BioEquin FT - V/NRP/20/0021 Bioveta, ,a.s., Čehija QI05AL01 horses Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated equine influenza virus, strain A/Equi 2/Brno 08 (American type) H3N8, Inactivated equine influenza virus, strain A/Equi 2/ Morava 95 (European type) H3N8, Tetanus toxoid
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 23102020LI (23-Oct-2020)
Labelling text: [DOCX] 23102020M (23-Oct-2020)
Summary of product characteristics: [DOCX] 23102020ZA (23-Oct-2020)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/20/0021-01 2 Stikla flakons, 1 deva -
V/NRP/20/0021-02 5 Stikla flakons, 1 deva -
V/NRP/20/0021-03 10 Stikla flakons, 1 deva -
V/NRP/20/0021-04 1 Stikla flakons, 5 deva -
V/NRP/20/0021-05 10 Stikla flakons, 5 deva -
MELCAM 1.5 mg/ml 1.5 mg/ml V/NRP/22/0009 Bioveta, a.s., Čehija QM01AC06 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 23-Feb-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 260722LI (26-Jul-2022)
Labelling text: [DOCX] 260722M (26-Jul-2022)
Summary of product characteristics: [DOCX] 260272ZA (26-Jul-2022)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/22/0009-01 1 Polietilēna pudele, 10 ml -
V/NRP/22/0009-02 1 Polietilēna pudele, 30 ml -
V/NRP/22/0009-03 1 Polietilēna pudele, 100 ml -
Intramar LC - V/NRP/20/0064 Bioveta, a.s., Čehija QJ51RV01 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate, Prednisolone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 26012021LI (26-Jan-2021)
Labelling text: [DOCX] 26012021M (26-Jan-2021)
Summary of product characteristics: [DOCX] 26012021ZA (26-Jan-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/20/0064-01 24 Injektors, 4 g -

3081 record

© Food and veterinary service · 2026 Cookies policy